BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 6488215)

  • 21. Ovarian and endometrial cancers.
    Mant JW; Vessey MP
    Cancer Surv; 1994; 19-20():287-307. PubMed ID: 7895220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The estimated effect of oral contraceptive use on the cumulative risk of epithelial ovarian cancer.
    Gross TP; Schlesselman JJ
    Obstet Gynecol; 1994 Mar; 83(3):419-24. PubMed ID: 8127536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.
    McGuire V; Felberg A; Mills M; Ostrow KL; DiCioccio R; John EM; West DW; Whittemore AS
    Am J Epidemiol; 2004 Oct; 160(7):613-8. PubMed ID: 15383404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the etiology of anal squamous carcinoma.
    Frisch M
    Dan Med Bull; 2002 Aug; 49(3):194-209. PubMed ID: 12238281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of ovarian cancer in women with prior hysterectomy in Japan.
    Yaegashi N; Sato S; Yajima A
    Gynecol Oncol; 1998 Mar; 68(3):244-6. PubMed ID: 9570974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective study of the transient decrease in ovarian cancer risk following childbirth.
    Liu Q; Lambe M; Baik I; Cnattingius S; Riman T; Ekbom A; Adami HO; Hsieh CC
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2508-13. PubMed ID: 17164377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee.
    Whittemore AS; Wu ML; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M
    Am J Epidemiol; 1988 Dec; 128(6):1228-40. PubMed ID: 3195564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
    Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
    J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased risk of second cancer among patients with ovarian borderline tumors.
    Bouchardy C; Fernandez S; Merglen A; Usel M; Fioretta G; Rapiti E; Schubert H; Pelte MF; Chappuis PO; Vlastos G
    Gynecol Oncol; 2008 May; 109(2):210-4. PubMed ID: 18377966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Endocrine and psychological problems in women subjected to tubal sterilization].
    Cappa F; Mascaretti G; Barchiesi S; Iagnemma G; Barbati D; Marinacci S; Pozzi V
    Patol Clin Ostet Ginecol; 1984; 12(3):209-13. PubMed ID: 12267497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.
    Olsen JH; Seersholm N; Boice JD; Krüger Kjaer S; Fraumeni JF
    Br J Cancer; 1999 Feb; 79(3-4):673-9. PubMed ID: 10027348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Premature recourse to tubal ligation in Quebec: some undesirable consequences?].
    Marcil-gratton N
    Sociol Soc; 1987 Apr; 19(1):83-95. PubMed ID: 12315211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tubal ligation and the risk of ovarian cancer: review and meta-analysis.
    Cibula D; Widschwendter M; Májek O; Dusek L
    Hum Reprod Update; 2011; 17(1):55-67. PubMed ID: 20634209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical procedures associated with risk of ovarian cancer.
    Kreiger N; Sloan M; Cotterchio M; Parsons P
    Int J Epidemiol; 1997 Aug; 26(4):710-5. PubMed ID: 9279601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence.
    Riman T; Persson I; Nilsson S
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):695-707. PubMed ID: 10209555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study.
    Hankinson SE; Hunter DJ; Colditz GA; Willett WC; Stampfer MJ; Rosner B; Hennekens CH; Speizer FE
    JAMA; 1993 Dec; 270(23):2813-8. PubMed ID: 8133619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical cytology screening after tubal ligation.
    Cohen MM; Roos NP
    Am J Prev Med; 1986; 2(4):220-5. PubMed ID: 3453184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of postpartum tubal sterilization on milk production].
    Vytiska-Binstorfer E
    Zentralbl Gynakol; 1989; 111(16):1124-7. PubMed ID: 2816156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endometrial pathological changes after Fallopian ring tubal ligation.
    de Cristofaro D; Zancanari C; Fiaccavento S; Pezzoli C
    Endoscopy; 1982 Jul; 14(4):139-40. PubMed ID: 7094900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
    Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
    Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.